What does the Government’s new National Cancer Plan mean for people with leukaemia? In our latest blog, we take an in-depth look at the commitments that could transform diagnosis, treatment and care for leukaemia patients. 👇 www.leukaemiauk.org.uk/news/nationa...

📢 A huge win for #WorldCancerDay! The Government has announced a new metric to track early diagnosis for leukaemia, as part of the National Cancer Plan. We’ve campaigned for this commitment & will work to ensure it delivers for leukaemia patients. 🧡

With the National Cancer Plan set to be published tomorrow, our CEO Fiona Hazell sets out why the Government must urgently commit to earlier diagnosis targets for leukaemia - to improve outcomes and to save lives healthcaretoday.com/article/comm...

This week, the Government will launch its National Cancer Plan for England. We’re keeping you updated with the latest developments - including a £200m investment in local cancer care and greater access to trials for rare cancer patients - and our response. www.leukaemiauk.org.uk/news/latest-...

Could blocking a specific signalling pathway weaken AML cells and pave the way for new targeted treatments? Researchers have developed a drug designed to block key proteins found in Interleukin-1 (IL-1) - a signalling pathway relied upon by AML cells. 🔗 medicine.iu.edu/news/2026/01...

It was great to see the Rare Cancers Bill pass its Second Reading in the House of Lords last week. Thank you to Baroness Delyth Morgan for speaking about the poor survival rates for AML and raising the issues in leukaemia that the bill hopes to address. 🤞

Congrats to Dr Matthew Blunt & team on their latest publication, revealing findings which could help to treat autoimmune disease. 👏 A great example of how discoveries in blood cancer research can drive progress across other areas of medicine! ✨ academic.oup.com/cei/advance-...

We’re thrilled to hear that patients are already receiving Aucatzyl, a novel CAR-T therapy for B-ALL, less than a month after it was approved for use on the NHS. We’re proud to have advocated for its approval with @anthonynolan.bsky.social @leukaemiacare.bsky.social 🧡 www.bbc.co.uk/news/article...

Just incredible! Did you know that umbilical cord blood is rich in stem cells, and can be used for stem cell transplants - a crucial treatment option for many leukaemia patients? 🩸 www.bbc.co.uk/news/article...

A fascinating study by our co-funded researcher, Dr Katrin Ottersbach @edinburgh-uni.bsky.social, brings us closer to understanding why infant leukaemia is so hard to treat - and how future therapies might better target the disease. 🔗 www.exphem.org/article/S030...

A fantastic start to the year! Venetoclax with obinutuzumab has been approved on the NHS in England for people with untreated CLL, expanding access to a fixed-duration, targeted first-line treatment option. 👏

Are you enthusiastic about research and its potential to improve our understanding of leukaemia, develop kinder treatments and enhance patient care? Apply to be our next Research Manager 👉 www.leukaemiauk.org.uk/about-us/wor...

📢 Gentler, smarter and more personalised therapies are reshaping the future of leukaemia treatment and care. We took a deep dive into some of the key takeaways from this year’s American Society of Haematology (ASH) conference. 🩸 #ASH25 @ash.hematology.org www.leukaemiauk.org.uk/stories/rese...

Last week, we shared the fantastic news about BE-CAR7 - a world-first therapy using CRISPR technology to treat T-cell leukaemia. 🔬 But what exactly is CRISPR? How is it different from standard CAR-T therapy? And why is it such a big deal? 👇 www.leukaemiauk.org.uk/stories/rese...

It was a pleasure to attend @ash.hematology.org this week and learn about all of the promising advancements in leukaemia treatment and care - from gentler treatments for AML to next-gen CAR-T therapies. Look out for our upcoming blog for a deeper dive! #ASH25 🩸

A major breakthrough! A world-first therapy - BE-CAR7 - is using base-edited immune cells to treat T-cell acute lymphoblastic leukaemia (T-ALL) - one of the most aggressive and hardest-to-treat types of leukaemia. https://www.bbc.co.uk/news/articles/cj38ymeyg4mo

We are delighted to announce further funding into ground-breaking research in 2026, by continuing our investment in early career scientists & clinicians! 📢 Applications for our 2026 John Goldman Fellowships are now open. Find out more: www.leukaemiauk.org.uk/research-and...

📢 A significant step forward in expanding treatment options for B-ALL. We’re thrilled that Aucatzyl - a CAR-T cell therapy for treating relapsed or refractory B-cell acute lymphoblastic leukaemia - has been approved for use on the NHS in England. www.leukaemiauk.org.uk/news/leukaem...

How incredible is this?! Huge congratulations and a big thank you to Shaun and Salim, who completed the world’s most dangerous dive to raise funds for life-changing leukaemia research in memory of their friend, Trish. 🧡👏 www.express.co.uk/news/uk/2135...

The recipient of our 2025 Patient Care Pioneer Award: Dr Sarah Stapleton 🏆 Dr Stapleton will look at the psychological support that leukaemia patients might need, and develop a framework to help guide healthcare professionals. www.leukaemiauk.org.uk/research-and...

Major breakthrough for T-ALL! Researchers have identified a previously unknown subtype, which can be detected using routine tests. 👏 This means clinicians could soon pinpoint high-risk cases at diagnosis & personalise treatment for children with T-ALL. bioengineer.org/breakthrough...

This is deeply concerning. Early diagnosis is crucial for successful treatment in all cancers, including leukaemia, which is why we’re calling on the Government to commit to urgently tackling delays in early diagnosis in their upcoming National Cancer Plan. www.bbc.co.uk/news/article...

Last chance to share your views! How do you want to hear about the impact of your incredible support? We want to make sure that you’re the first to know about the life-saving research we’re funding, all thanks to you. 🧡 Have your say: https://survey.alchemer.eu/s3/90953656/a60c0b257002

Promising news! Researchers have found that statins, a cholesterol-lowering drug, could help to tackle “chemo brain” - a debilitating cognitive side effect for many cancer patients. 🤞 www.independent.co.uk/news/health/...

We want to hear from you - our fantastic supporters! How can we keep you informed about the impact of your incredible support, and how it’s helping us to fund life-changing leukaemia research? Fill in our short survey by midnight on Mon 10th Nov: survey.alchemer.eu/s3/90953656/...

A decade of bold ideas, brilliant minds & real impact. 💡 Our John Goldman Fellowships are driving progress in leukaemia research, from identifying new drug targets to repurposing existing medicines. Read more: www.leukaemiauk.org.uk/stories/a-de...

We’re continuing to fund incredible research and talented scientists who are working hard to find kinder, more effective treatments to stop leukaemia devastating lives. But none of this would be possible without your support. 🧡 Here are a few words from our researchers… 🎥

Researchers have used gene-editing tools to map mutations in the ABL1 kinase domain - a critical component driving CML - and identify which of these mutations are resistant to certain drugs, opening the door to more personalised treatment options. 👏 scienmag.com/enhanced-res...

Thank you @clivejonesmp.bsky.social for leading today's Westminster Hall debate and raising the issues faced by leukaemia patients. Our thanks also to @drscottarthurmp.bsky.social for echoing our call to ensure the upcoming 10-Year Workforce Plan enables and supports the National Cancer Plan.

Exciting news! Researchers have now uncovered why proteasome inhibitors, a class of drugs that work well in multiple myeloma, aren’t as effective in AML patients - and how to change this. 👏 Read more: www.technologynetworks.com/tn/news/dual...

Thank you Gavin Williamson MP for raising Ruth’s case in Parliament and asking the Government what steps are being taken to support patients with AML. We welcome @ashleydaltonmp.bsky.social's recommitment to improving AML survival, something we are calling for in the upcoming National Cancer Plan.

We’re thrilled to have co-supported Molecular Haemopoiesis 2025, bringing together leading researchers exploring blood cell development. 🩸 It was great to see some of our past & present John Goldman Fellows deliver fascinating talks, and see such impactful science in action! 🔬

We’re delighted to announce our second John Goldman Fellow for 2025 and this year’s Olive Boles Innovation Award winner - Dr Gillian Horne from @uofglasgow.bsky.social 🔬 Her research focuses on building better diagnostic tools to treat Ph+ ALL. Read more: www.leukaemiauk.org.uk/research-and...

⚠️ Last chance to make your voice heard and tell the Government to stop avoidable delays in leukaemia diagnosis. Join us in demanding better for leukaemia patients ➡️ action.leukaemiauk.org.uk/count-us-in #CountUsIn

So humbled to receive the John Goldman Fellowship from @leukaemiauk.bsky.social to identify new metabolic vulnerabilities of B-ALL for future gentler and more targeted therapies. @edinuni-irr.bsky.social @cmvm-edinburghuni.bsky.social @edinburgh-uni.bsky.social

📢 We’re funding two new groundbreaking studies, aimed at developing kinder, more effective treatments for acute lymphoblastic leukaemia (ALL). Meet @comazzettolab.bsky.social from @edinuni-irr.bsky.social - one of our two new John Goldman Fellows for 2025. www.leukaemiauk.org.uk/research-and...

Unfortunately, Tracey’s story isn’t uncommon. A shocking 1 in 4 leukaemia patients experience avoidable delays in their diagnosis. It’s time to change this. 💪 Join us in calling for the Government to commit to taking action ➡️ action.leukaemiauk.org.uk/count-us-in #CountUsIn

This month, we’re celebrating a very special milestone: 10 years of our John Goldman Fellowship funding programme. ✨ Over the past decade, our Fellowships have empowered early-career researchers to pursue ideas that push the boundaries of science. 🔗: www.leukaemiauk.org.uk/stories/rese...

A fantastic few days at the #Lab25 conference, speaking with MPs and policymakers, including @rthonwesstreeting.bsky.social, about our #CountUsIn campaign and the need for the upcoming National Cancer Plan to stop avoidable delays in leukaemia diagnosis. (1/2)

Thanks @tobyperkinsmp.bsky.social for taking time at #Lab25 to meet us. We discussed the importance of ensuring that earlier leukaemia diagnosis is prioritised across the NHS.

Really valuable conversation with @samcarling.bsky.social at #Lab25 about ending avoidable delays in leukaemia diagnosis. Thank you for supporting our Count Us In campaign.

It was a pleasure to meet @julietcampbellmp.bsky.social at #Lab25 and share how our Count Us In campaign is calling for earlier leukaemia diagnosis to be a priority in the new National Cancer Plan

Important conversation with @sarahowen.org.uk MP at #Lab25 about the need for urgent full blood counts to help diagnose (or rule out) leukaemia earlier. Thank you for your support.

Thank you @danfrancis02.bsky.social for taking the time to hear about the realities of leukaemia diagnostic delays. We look forward to your support in ensuring the National Cancer Plan drives change.

Great to speak with @afzalkhanmcr.bsky.social about the shocking delays too many leukaemia patients face. We need the National Cancer Plan to commit to faster diagnosis. #CountUsIn #Lab25

We were grateful to speak with Anas Sarwar at #Lab25 about the challenges in diagnosing leukaemia early and why addressing them must become a priority in Scotland

We were grateful to speak with Anas Sarwar at #Lab25 about the challenges in diagnosing leukaemia early and why addressing them must become a priority in Scotland

Thank you @imogenwalker.bsky.social for visiting our stand at #Lab25 and speaking with our Community Champion, Jonathan, about the importance of early diagnosis We’re calling on Government to make sure the National Cancer Plan delivers for people affected by leukaemia.

We’re proud to be members of the Wales Cancer Alliance and work together to drive improvements for people with cancer in Wales. This manifesto sets out vital recommendations and we urge all political parties to commit to delivering them if they form the next Welsh Government.

Great to talk to @abarroscurtis.bsky.social about our Count Us In campaign and the need to address the delays in diagnosing leukaemia in Wales